<SEC-DOCUMENT>0000886163-16-000152-index.html : 20160303
<SEC-HEADER>0000886163-16-000152.hdr.sgml : 20160303
<ACCEPTANCE-DATETIME>20160303084623
ACCESSION NUMBER:		0000886163-16-000152
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20151119
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160303
DATE AS OF CHANGE:		20160303

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33093
		FILM NUMBER:		161479620

	BUSINESS ADDRESS:	
		STREET 1:		11119 NORTH TORREY PINES ROAD
		STREET 2:		SUITE 200
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		11119 NORTH TORREY PINES ROAD
		STREET 2:		SUITE 200
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>lgnd_form8-kxavireolicense.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: lgnd_form8-kxavireolicense.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>lgnd-vireolicenseagreement.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 2 - file: lgnd-vireolicenseagreement.htm

</DOCUMENT>
</SEC-DOCUMENT>